-
Izindaba Ezijabulisayo | Indawo Yokukhiqiza I-Semaglutide API Enkulu YaseChina Idlula Ukuhlolwa kwe-US FDA
Kusukela ngomhla ka-Agasti 26 kuya ku-Agasti 30, 2024, indawo yokukhiqiza i-peptide ye-JYMed, i-Hubei JX Bio-Pharmaceutical Co., Ltd., iphumelele ngempumelelo ukuhlolwa kwendawo okwenziwa yi-US Food and Drug Administration (FDA). Ukuhlola kuhlanganisa izindawo ezibalulekile ...Funda kabanzi -
2024 CPHI Milan Pharmaceutical Exhibition Recap
01. Uhlolojikelele Lombukiso Ngomhla ziyisi-8 kuMfumfu, uMbukiso Womhlaba Wonke Wezemithi we-CPHI wango-2024 waqala e-Milan. Njengomunye wemicimbi yaminyaka yonke ebaluleke kakhulu embonini yezemithi yomhlaba wonke, uhehe ababambiqhaza abavela emazweni nezifunda eziyi-166. Ngokudlula...Funda kabanzi -
Izindaba Ezijabulisayo | I-JYMed's Liraglutide API Ithola Isitifiketi Se-WC
Ngomhla ziyi-12 kuMfumfu, 2024, i-JYMed's Liraglutide API yathola isitifiketi Sokuqinisekisa Okubhaliwe (WC), okumaka isinyathelo esibalulekile sokuthunyelwa ngempumelelo kwe-API emakethe ye-EU. I-WC (Isiqiniseko Esibhaliwe)...Funda kabanzi -
Izindaba Ezijabulisayo: I-JYMed's Leuprorelin Acetate Idlula Ukuhlolwa Kokubhaliswa Kwezidakamizwa
Muva nje, i-JYMed Technology Co., Ltd. imemezele ukuthi i-Leuprorelin Acetate, ekhiqizwa inkampani engaphansi kwayo i-Hubei JX Bio-Pharmaceutical Co., Ltd., iphumelele ngempumelelo ukuhlolwa kokubhaliswa kwezidakamizwa. Imakethe Yezidakamizwa Yasekuqaleni...Funda kabanzi -
Sihalalisela I-Tirzepatide ye-JYMed Iqeda Ukugcwalisa kwe-US-DMF
I-JYMed Technology Co., Ltd. iyajabula ukumemezela ukuthi umkhiqizo wayo, i-Tirzepatide, iqede ngempumelelo ukubhaliswa kwe-Drug Master File (DMF) ne-US FDA (Inombolo ye-DMF: 040115) futhi yathola I-Acknowl ye-FDA...Funda kabanzi -
U-JYMed ufunda i-PCT 2024 e-Shanghai
I-PCT2024 Personal Care Technology Summit & Exhibition umcimbi onethonya elikhulu esifundeni sase-Asia-Pacific, ogxile ekushintshaneni kobuchwepheshe kanye nemibukiso embonini yemikhiqizo yokunakekelwa komuntu siqu.Inkundla izohlanganisa izici ezihlukahlukene zemboni yokunakekelwa komuntu siqu, kuhlanganise nezobuchwepheshe ku...Funda kabanzi -
I-JYMed Peptide ikumema ukuthi uhambele uMbukiso Wezithako Zezimonyo wase-Korea wango-2024
Indawo: I-Korea International Exhibition Centre Usuku: Julayi 24-26, 2024 Isikhathi: 10:00 AM - 5:00 PM Ikheli: I-COEX Exhibition Center Hall C, 513 Yeongdong-daero, Gangnam-gu, Seoul, 06164 In-cosmetics iyinhlangano iqembu lemibukiso yamazwe ngamazwe elihamba phambili ekunakekelweni komuntu siqu...Funda kabanzi -
Umbiko Omusha Womthetho
1. Imithetho Emisha Yokubhaliswa Kwe-FDA Yezimonyo Zezimonyo Zase-US Ngaphandle Kokubhaliswa Kwe-FDA Izovinjelwa Ukudayiswa.Ngokomthetho Wesimanje Wokulawulwa Kwezimonyo wango-2022, osayinwe nguMongameli Biden ngomhla ka-29 Disemba 2022, zonke izimonyo ezithunyelwa e-United States kufanele zibe yi-FDA. -bhalisa...Funda kabanzi -
Isaziso Seholide Lomkhosi Wasentwasahlobo
Sicela waziswe ukuthi ihhovisi lethu lizovalwa kusukela ngo-Feb. 4 kuya ku-Feb.18 ngenxa yoMkhosi Wasentwasahlobo. Noma imaphi ama-oda azokwamukelwa kodwa ngeke acutshungulwe kuze kube Feb.19, usuku lokuqala lwebhizinisi ngemva koMkhosi Wasentwasahlobo. Siyaxolisa nganoma yikuphi ukuphazamiseka okubangelwe.Funda kabanzi -
2023 I-API yesi-88 ECHINA
Ulwazi mayelana ne-JYMed ngo-2023 API CHINA 【esizeni】 Ngaphansi kobuholi bePhini Lomphathi Omkhulu u-Zhi Qin, i-Shenzhen JYMed Technology Co.,Ltd. (okuzobizwa kamuva nge-JYMed) ubambe iqhaza kulo mbukiso omkhulu. I-JYMed ibonise imikhiqizo enenzuzo i-Semaglutide, i-Liraglutide, i-Tirzepatide, i-O...Funda kabanzi -
Siyakwamukela ukuzohlangana nathi embukisweni we-API e-Qindao China JYMed stock: N4K32
Funda kabanzi -
I-JYMed ihlangane nawe kwa-PCHi
Ngemva kweminyaka emibili yokulindela, umbukiso we-2023 China International Cosmetics Personal and Home Care Raw Materials Exhibition (PCHi) wawukade ubanjelwe e-Guangzhou Canton Fair Complex ngo-February 15-17, 2023. ...Funda kabanzi -
I-Semeglutide API ye-Shenzhen JYMed yamukelwe yiqeqebana lokuqala le-NMPA yasekhaya futhi Ibhaliswe ku-US FDA (DMF No. 036009) enesimo esithi “A”.
NgoMeyi 2022, i-Shenzhen JYMed Technology Co., Ltd. (ngemuva kwalokhu ebizwa nge-JYMed peptide) yathumela isicelo sokubhaliswa kwe-semaglutide API kwa-US Food and Drug Administration (FDA) (inombolo yokubhalisa ye-DMF: 036009), Isidlulile. ukubuyekezwa kobuqotho, kanye nesimo samanje...Funda kabanzi -
I-Copper Peptides: Izinzuzo Zokunakekelwa Kwesikhumba Nezinwele nokuthi Zisetshenziswa Kanjani
Sifaka imikhiqizo esicabanga ukuthi abafundi bethu bazoyithola iwusizo. Singase sizuze ikhomishini encane uma uthenga ngesixhumanisi esikuleli khasi. Lena inqubo yethu. Ama-peptide avela ngokwemvelo ama-amino acid asiza ukukhiqiza i-collagen ne-elastin, izicubu ezimbili ezixhumeneyo ezinomthwalo we...Funda kabanzi -
I-Ozempic (Semaglutide) Umjovo: Ukusetshenziswa, Imiphumela Eseceleni, Umthamo
U-Erica Prouty, u-PharmD, ungusokhemisi ochwepheshe osiza iziguli ngemithi nezinsizakalo zekhemisi eNyakatho Adams, Massachusetts. Ezifundweni zezilwane ezingezona ezomuntu, i-semaglutide iboniswe ukuthi ibangele izicubu ze-C-cell yegilo kumagundane. Kodwa-ke, akucaci ukuthi le ngozi idlulela nakubantu....Funda kabanzi -
Ukukhishwa kwe-fatty acids ekutholakaleni kwezidakamizwa ze-peptide namaprotheni
Siyabonga ngokuvakashela i-Nature.com. Inguqulo yesiphequluli oyisebenzisayo inosekelo olulinganiselwe lwe-CSS. Ukuze uthole ulwazi olungcono kakhulu, sincoma ukuthi usebenzise isiphequluli esibuyekeziwe (noma ukhubaze i-Compatibility Mode ku-Internet Explorer). Okwamanje, ukuze siqinisekise ukwesekwa okuqhubekayo, sizonikeza isayithi ngaphandle kwe-s...Funda kabanzi -
Isidakamizwa esisha se-Class I se-JYMed senze inqubekelaphambili ebonakalayo, i-Laipushutai kulindeleke ukuthi ibe umugqa wokuqala wezidakamizwa ze-UC.
Ngomhla zingama-29 kuNhlangulana wezi-2017, ukuthuthukiswa kwe-Laipushutai, imithi emisha yekilasi I ngokuthuthuka ngokubambisana kwe-JYMed kanye ne-Guangzhou Linkhealth Medical Technology Co., Ltd., kwenziwe inqubekelaphambili ebonakalayo. Isimemezelo se-IND somuthi samukelwe yi-CFDA. I-JYMed ne-Guangzhou Lin...Funda kabanzi -
Izindaba NemicimbiI-Peptide Products Division e-JYMed idlulise ngokungenaphutha ukuhlolwa kwendawo okuvela ku-FDA.
Sihalalisela ngokufudumele uphiko lwethu lwemikhiqizo ye-Polypeptide ngokuphasisa ngempumelelo i-US FDA yokuhlola indawo "engenasici"! Ukwedlula ukuhlolwa kwe-FDA endaweni "ngokungenasici" kuwumcimbi omkhulu emlandweni wethu wokuthuthukiswa kwe-cGMP. Akusho nje kuphela ukuthi i-API yethu ine-obt...Funda kabanzi